Bank of America Analysts Give Novartis (NOVN) a CHF 87 Price Target

Nestle SA (VTX:NESN) has been given an average rating of "Hold" by the nineteen analysts that are covering the firm, Marketbeat Ratings reports. The brokerage now has a neutral rating on the healthcare company's stock. The stock presently has a consensus rating of "Hold" and a consensus target price of CHF 87.31.

A number of brokerages recently weighed in on NESN. Finally, UBS set a CHF 92 price objective on Nestle and gave the company a "buy" rating in a research report on Thursday, October 19th. Kepler Capital Markets set a CHF 87 price target on Novartis and gave the company a buy rating in a research report on Monday, August 28th. set a CHF 90 price target on Novartis and gave the company a buy rating in a research report on Tuesday, September 19th. J P Morgan Chase & Co set a CHF 97 price objective on Nestle and gave the company a "buy" rating in a research report on Tuesday, December 5th. Finally, Societe Generale set a CHF 89 target price on shares of Nestle and gave the company a "neutral" rating in a research note on Wednesday, September 27th.

Goldman Sachs Group Inc set a CHF 335 price target on Roche Holding Ltd. (VTX:ROG) in a research note issued to investors on Friday, May 26th.

Shares of Nestle (NESN) traded down CHF 0.15 during trading on Thursday, hitting CHF 85.35. 5,540,000 shares of the company traded hands, compared to its average volume of 5,220,000. Roche Holding has a 12-month low of CHK 218.30 and a 12-month high of CHK 273.00.

TRADEMARK VIOLATION NOTICE: "Roche (ROG) PT Set at CHF 254 by Deutsche Bank" was reported by The Lincolnian Online and is the sole property of of The Lincolnian Online.

Altre Notizie